Drug intelligence / Profile preview

Yiqi-Qushi-Fangbi-Fang

Development stage
Unknown
Lead developer
Guangdong Provincial Hospital of Traditional Chinese Medicine
Administration
Oral
01

Overview

Yiqi-Qushi-Fangbi-Fang (also known as Formulation A or Decoction A) is an investigational traditional Chinese medicine (TCM) compound developed by the Guangdong Provincial Hospital of Chinese Medicine for the prevention of rheumatoid arthritis (RA). It is a novel formulation composed of eight herbs, representing an adaptation of two classic TCM formulas: Huangqi-Guizhi-Wuwu-Tang (HGWT) and Yiyiren-Tang (YYRT). The drug is administered orally and is specifically being studied in individuals at high risk for RA—those who are positive for anti-cyclic citrullinated peptide (anti-CCP) antibodies but have not yet developed clinical synovitis. Its mechanism of action involves broad anti-inflammatory and immunomodulatory effects, including the regulation of inflammatory cytokines and the inhibition of the NF-kappa-B, Interleukin-17, PI3K/Akt, and HIF-1-alpha signaling pathways.

Other names
Yiqi Qushi Fangbi Fang类风湿关节炎预防A方
02

Targets

AKT (RAC-alpha serine/threonine-protein kinase)NF-κBPI3K (Phosphoinositide-3-kinase regulatory subunit 6)HIF1A (Hypoxia-inducible factor 1-alpha)

Beyond the preview

Go deeper on Yiqi-Qushi-Fangbi-Fang.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yiqi-Qushi-Fangbi-Fang.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call